Canada Life
CPRX

Canada Life’s Catalyst Pharmaceutical CPRX Stock Holding History

Canada Life’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Sell
95,314
-3,267
-3% -$77.8K ﹤0.01% 1093
2025
Q4 		$2.3M Sell
98,581
-31,442
-24% -$700K ﹤0.01% 1112
2025
Q3 		$2.54M Buy
130,023
+2,323
+2% +$47.8K ﹤0.01% 1129
2025
Q2 		$2.77M Buy
127,700
+5,677
+5% +$134K ﹤0.01% 1053
2025
Q1 		$2.96M Sell
122,023
-11,184
-8% -$252K 0.01% 1030
2024
Q4 		$2.78M Sell
133,207
-4,007
-3% -$86.1K ﹤0.01% 1117
2024
Q3 		$2.73M Sell
137,214
-3,725
-3% -$69.1K ﹤0.01% 1165
2024
Q2 		$2.18M Sell
140,939
-6,306
-4% -$98.2K ﹤0.01% 1250
2024
Q1 		$2.35M Buy
147,245
+16,599
+13% +$250K ﹤0.01% 1166
2023
Q4 		$2.19M Sell
130,646
-8,488
-6% -$116K ﹤0.01% 1208
2023
Q3 		$1.62M Buy
139,134
+8,348
+6% +$112K ﹤0.01% 1312
2023
Q2 		$1.76M Sell
130,786
-4,327
-3% -$62.3K ﹤0.01% 1265
2023
Q1 		$2.24M Sell
135,113
-9,531
-7% -$157K 0.01% 1173
2022
Q4 		$2.69M Buy
144,644
+21,671
+18% +$334K 0.01% 1071
2022
Q3 		$1.57M Buy
122,973
+117,547
+2,166% +$1.39M ﹤0.01% 1289
2022
Q2 		$38K Hold
5,426
– – ﹤0.01% 2109
2022
Q1 		$48K Hold
5,426
– – ﹤0.01% 2168
2021
Q4 		$37K Hold
5,426
– – ﹤0.01% 2252
2021
Q3 		$29K Hold
5,426
– – ﹤0.01% 2363
2021
Q2 		$31K Hold
5,426
– – ﹤0.01% 2394
2021
Q1 		$25K Hold
5,426
– – ﹤0.01% 2473
2020
Q4 		$18K Hold
5,426
– – ﹤0.01% 2556
2020
Q3 		$16K Hold
5,426
– – ﹤0.01% 2478
2020
Q2 		$25K Hold
5,426
– – ﹤0.01% 2438
2020
Q1 		$21K Hold
5,426
– – ﹤0.01% 2357
2019
Q4 		$20K Buy
+5,426
New +$25.4K ﹤0.01% 2494
2019
Q3 		– Sell
-10,227
Closed -$39K – 1376
2019
Q2 		$39K Buy
+10,227
New +$44.2K ﹤0.01% 2500

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Canada Life's CPRX Position: Q1 2026 in Review

Canada Life reduced its Catalyst Pharmaceutical (CPRX) stake by 3.3% in Q1 2026, selling an estimated $77.8K and leaving 95,314 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Canada Life first reported a position in CPRX in Q2 2019 and has held it in 27 quarters since. The position peaked at $2.96M in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Canada Life held 95,314 shares of Catalyst Pharmaceutical worth $2.36M as of Q1 2026.
  • Canada Life sold 3,267 Catalyst Pharmaceutical shares in Q1 2026, an estimated $77.8K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1093 holding.
  • Canada Life first reported a position in Catalyst Pharmaceutical in Q2 2019 and has held it in 27 quarters since.
  • Canada Life's Catalyst Pharmaceutical position peaked at $2.96M in Q1 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.